Skip to main content
. 2013 Sep 17;1:e168. doi: 10.7717/peerj.168

Table 1. Incident use in community-dwelling older adults (65+).

Medications SGAs FGAs BZDs/ZOP, ZAL BZDs/ZOP, ZAL + SGA
Users/1,000 Year 1998 0.21 1.88 13.14 0.06
Users/1,000 Year 2009 1.63 1.03 13.66 0.15
Change in rate per quarter 1.02* 0.98* 1.00 NS 1.01*
Age effect 65–84 vs. 85+ 0.44* 0.85* 1.08* 0.60*
SES effect low vs. high 1.10* 1.14* 1.00 NS 1.09 NS
Region effect rural vs. urban 0.88* 1.51* 1.01 NS 1.02 NS
Sex effect male vs. female 0.91* 0.86* 0.73* 1.17*

Notes.

Results for change in quarterly rate, age, SES, region and sex effects are presented as relative rates (adjusted for age, SES, region, sex and time).

SGAs
second generation antipsychotics
FGAs
first generation antipsychotics
BZDs/ZOP, ZAL
benzodiazepines, zopiclone, zaleplon
NS
not significant
SES
socioeconomic status
*

Indicates a statistically significant effect (p < 0.05).